Kanglin Biotechnology (Hangzhou) Co., Ltd.
Kanglin Biotechnology (Hangzhou) Co., Ltd.
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Β-Thalassemia Treatment with KL003 Cell Injection | Transfusion-dependent Beta-Thalassemia | Recruiting | Phase 1 / Phase 2 | 2025-03-10 | NCT06280378 |